Navigation Links
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Date:1/3/2008

the following trade names; COLLATAMP(R) G, COLLATAMP(R) EG, SULMYCIN(R) IMPLANT, GARAMYCIN(R) SCHWAMM, DURACOL(R), DURACOLL(R), GENTACOL(R), GENTACOLL(R), GARACOL(R), GARACOLL(R), and CRONOCOL(R). In 2005, Innocoll acquired the worldwide marketing rights for this product from Essex Chemis AG, an affiliated company of Schering-Plough Corporation (NYSE: SGP) and in August 2007 sold its marketing rights, with the exception of the US, to EUSA Pharma. Gentamicin Surgical Implant is currently in phase 3 development in the US for the prevention of surgical site infections. Other late stage pharmaceutical products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, please visit http://www.innocollinc.com.


'/>"/>
SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... N.C. , March 31, 2015 PGI ... capabilities in North America at ... facility. The anticipated plant expansion is centered ... a need for differentiated products for personal care product ... state-of-the-art printing capabilities with in-line slitting and packaging, will ...
(Date:3/31/2015)... March 31, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a ... diseases and cholesterol gallstones, today announced financial results ... Fourth Quarter 2014 Highlights: , ... keynote address by Professor Rohit Loomba, MD, MHSc., ...
(Date:3/31/2015)... Mar. 27, 2015 Research and Markets ... of the "European Laboratory Information System (LIS) ... Type (Clinical Pathology Laboratory Information System, Anatomic Pathology ... report to their offering. The European ... at a CAGR of 7.6% from 2014 to ...
Breaking Medicine Technology:PGI Expands Manufacturing Capabilities At Mexico Plant 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
... BRUNSWICK, New Jersey, June 23, 2011 , ... a Piramal Group,Company and Chromocell Corporation ... and,therapeutics discovery, today signed an agreement under which O2h,will provide ... Chromocell.   "I have known O2h for ...
... 2011 Kevin Kline and four children with type ... to take immediate action to accelerate the research and ... the Senate Committee on Homeland Security and Government Affairs. ... of the Juvenile Diabetes Research Foundation,s (JDRF) 2011 Children,s ...
Cached Medicine Technology:O2h to Provide Chemistry Support to Chromocell 2Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward 2Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward 3Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward 4
(Date:3/31/2015)... March 31, 2015 Indosoft, developer of the ... 1.4 support in development of their 5.x line. The industry ... has been deployed around the world for more than a ... as a telephony platform, Q-Suite can fully embrace newer Asterisk ... call center software on Asterisk for more than a decade. ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The Walk a ... GMO controversy , just kicked off their 3rd research ... “substantial equivalence.” , “ Substantial Equivalence was and is ... states Eric Battersby, Director at Change The World Films. ... point well before GMOs even entered our food supply, just ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Russell Ashinoff ... Advanced Reconstruction. He was recently quoted in an Asbury ... by lymphatic issues, causing fluid retention and tissue swelling. ... to relieve and / or improve lymphedema symptoms. ... or alleviate the symptoms of lymphedema. The goal is ...
(Date:3/31/2015)... Calif. (PRWEB) March 31, 2015 ... distinction between mice and humans: how human livers ... PPARa, which activates liver regeneration. Normally, mouse PPARa ... human form, allowing mice to quickly regenerate damaged ... growth factor 21 (FGF21) can boost the regenerative ...
(Date:3/31/2015)... Indosoft, Inc., developers of contact center software for ... TCP configuration for all SIP devices in Q-Suite 5.9. Q-Suite ... center ACD (Automatic Call Distributor) system on Asterisk to ... to all SIP devices gives users an additional option for ... IP (VoIP) has primarily involved User Datagram Protocol (UDP), a ...
Breaking Medicine News(10 mins):Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2
... pain , THURSDAY, Dec. 24 (HealthDay News) -- Acetaminophen ... to relieve physical pain, but a new study suggests ... psychological pain of rejection. , Researchers assigned 62 healthy ... group took 1,000 milligrams of acetaminophen daily, while the ...
... 24 The U.S. Senate bill,s historic expansion of health ... the health care system to the medical and insurance industries. ... state governments to monitor and police these industries and fix ... the legislation requires every American to buy coverage under threat ...
... , SILVER SPRING, Md., Dec. 24 The American ... applauds Senate lawmakers for passing H.R. 3590, " The Patient ... approved by a vote of 60-39. ANA had urged passage of ... several sent to members of Congress, was read on the Senate ...
... , Dec. 24 The ... passage of legislation that holds the promise of more comprehensive ... for those without. , We are pleased that ... with our association,s principles for comprehensive health reform, and that ...
... Figitumumab fights tumors and appears to be well-tolerated, researchers say ... that the anticancer drug figitumumab might be an effective treatment ... and near the bone, mainly in teenage boys. , The ... to a report published in the Dec. 23 online edition ...
... , Bargaining Agreement Reached , ... Teamsters Local #929 will return to work today after voting ... American Red Cross Penn-Jersey Blood Region. , (Logo: ... employees who pack, ship and deliver blood to hospitals, assist ...
Cached Medicine News:Health News:Tylenol May Ease Headaches and Heartaches 2Health News:Tylenol May Ease Headaches and Heartaches 3Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 3Health News:Senate Passes Landmark Health Care Reform Bill 2Health News:APA Statement on Senate Passage of Health Care Reform Legislation 2Health News:American Red Cross Announces End to Teamsters Strike 2
Phaco Chopper, double ended; a combination of a modified MicroFinger and a pointed "quick chop" tip, in titanium...
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Medicine Products: